Enzoflam-CT Tablet contains Trypsin Chymotrypsin (100000 AU), a proteolytic enzyme combination widely used for its anti-inflammatory and analgesic properties. This medication is primarily indicated for the management of acute and chronic inflammatory conditions, including postoperative swelling, traumatic injuries, and musculoskeletal disorders such as arthritis and tendinitis. Trypsin and chymotrypsin act by breaking down proteinaceous inflammatory mediators, thereby reducing edema, pain, and promoting faster resolution of inflammation. Enzoflam-CT facilitates enhanced tissue repair and improves microcirculation, contributing to accelerated healing processes. It is often prescribed as an adjunct to conventional therapy in conditions characterized by excessive inflammation and pain. The tablet formulation ensures convenient oral administration with good bioavailability. Enzoflam-CT is generally well tolerated; however, it should be used cautiously in patients with hypersensitivity to proteolytic enzymes or those with bleeding disorders due to its fibrinolytic activity. Contraindications include active peptic ulcer, hemophilia, and severe hepatic or renal impairment. Dosage and duration of therapy should be individualized based on clinical response and severity of the condition. As with all medications, adherence to prescribed instructions and consultation with a healthcare professional prior to use is recommended to ensure safety and efficacy.